Mouse models of long QT syndrome

Journal of Physiology

Volumn 578, Issue 1, 2007, Pages 43-53

  Salama, Guy ^a   London, Barry ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV2.1; POTASSIUM CHANNEL KV4.2; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL MODEL; AUTONOMIC NERVOUS SYSTEM; ELECTROMYOGRAPHY; GENE MUTATION; HEART MUSCLE CELL; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME; MOUSE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; REVIEW; SUDDEN DEATH; SYNCOPE; ACTION POTENTIAL DURATION; AMINO TERMINAL SEQUENCE; APD75; APD90; GENE EXPRESSION; GENE LOCATION; GENETICALLY ENGINEERED MOUSE STRAIN; HEART RATE; HEART RATE VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; POTASSIUM CURRENT; PROTEIN EXPRESSION; SEX DIFFERENCE; SODIUM CURRENT; STRAIN DIFFERENCE; T WAVE; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEART; HUMANS; LONG QT SYNDROME; MICE; MICE, TRANSGENIC; MUTATION;

EID: 33845727027     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.118745     Document Type: Review

References (60)

1. + current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circ Res 83, 668-678.
2. Baker LC, London B, Choi BR, Koren G & Salama G (2000). Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86, 396-407.
3. Barry DM, Xu H, Schuessler RB & Nerbonne JM (1998). Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit. Circ Res 83, 560-567.
4. Bennett PB, Yazawa K, Makita N & George AL Jr (1995). Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683-685.
5. Berul CI, Aronovitz MJ, Wang PJ & Mendelsohn ME (1996). In vivo cardiac electrophysiology studies in the mouse. Circulation 94, 2641-2648.
6. K,slow. Am J Physiol Heart Circ Physiol 281, H1201-H1209.
7. Brunner M, Kodirov SA, Mitchell GF, Buckett PD, Shibata K, Folco EJ, Baker L, Salama G, Chan DP, Zhou J & Koren G (2003). In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype. Am J Physiol Heart Circ Physiol 285, H194-H203.
8. Casimiro MC, Knollmann BC, Ebert SN, Vary JC Jr, Greene AE, Franz MR, Grinberg A, Huang SP & Pfeifer K (2001). Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci U S A 98, 2526-2531.
9. + channel properties and QT heart rate adaptation in neonatal ankyrin B knockout mice. Circ Res 86, 441-447.
10. Demolombe S, Lande G, Charpentier F, van Roon MA, van den Hoff MJ, Toumaniantz G, Baro I, Guihard G, Le Berre N, Corbier A, de Bakker J, Opthof T, Wilde A, Moorman AF & Escande D (2001). Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation. Cardiovasc Res 50, 314-327.
11. + channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res 83, 95-102.
12. Drici MD, Baker L, Plan P, Barhanin J, Romey G & Salama G (2002). Mice display sex differences in halothane-induced polymorphic ventricular tachycardia. Circulation 106, 497-503.
13. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK & Berul CI (2000). Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol 279, H733-H740.
14. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA & Saffitz JE (1997). Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest 99, 1991-1998.
15. to,f and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res 97, 1342-1350.
16. to,s: Early afterdepolarizations, atrioventricular block, and ventricular arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 α subunit. Circ Res 87, 73-79.
17. Gutstein DE, Danik SB, Sereysky JB, Morley GE & Fishman GI (2003). Subdiaphragmatic murine electrophysiological studies: Sequential determination of ventricular refractoriness and arrhythmia induction. Am J Physiol Heart Circ Physiol 285, H1091-H1096.
18. Huang WY, Aramburu J, Douglas PS & Izumo S (2000). Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6, 482-483.
19. Jervell A & Lange-Nielsen F (1957). Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 54, 59-68.
20. Keating MT & Sanguinetti MC (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569-580.
21. Knollmann BC, Katchman AN & Franz MR (2001). Monophasic action potential recordings from intact mouse heart: Validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12, 1286-1294.
22. K,slow2 in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias. Am J Physiol Heart Circ Physiol 286, H368-H374.
23. to and confers susceptibility to ventricular tachycardia. Cell 107, 801-813.
24. Kupershmidt S, Yang T, Anderson ME, Wessels A, Niswender KD, Magnuson MA & Roden DM (1999). Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ Res 84, 146-152.
25. Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, Berger RD, Brandenburg SA, Litzi TJ, Bunton TE, Limb C, Francis H, Gorelikow M, Gu H, Washington K, Argani P, Goldenring JR, Coffey RJ & Feinberg AP (2000). Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest 106, 1447-1455.
26. Kr in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia. Mol Cell Biol 23, 1856-1862.
27. K,slow1 in mouse ventricular myocytes expressing a dominant negative Kv1.5α subunit. Am J Physiol Heart Circ Physiol 286, H319-H328.
28. London B (2001). Cardiac arrhythmias: From (transgenic) mice to men. J Cardiovasc Electrophysiol 12, 1089-1091.
29. London B (2004). Mouse models of cardiac arrhythmias. In Cardiac Electrophysiology: From Cell to Bedside, 4th edn, ed. Zipes DP & Jalife P, pp. 433-443. Saunders, Philadelphia.
30. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM & Salama G (2003). Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284, H431-H441.
31. K,slow and resistance to drug-induced qt prolongation. Circ Res 88, 940-946.
32. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF & Koren G (1998 a). Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci U S A 95, 2926-2931.
33. London B, Pan X-H, Lewarchik C & Lee JS (1998 b). QT interval prolongation and arrhythmias in heterozygous Merg1-targeted mice. Circulation 98, I-56.
34. + current. Circ Res 81, 870-878.
35. London B, Wang DW, Hill JA & Bennett PB (1998 c). The transient outward current in mice lacking the potassium channel gene Kv1.4. J Physiol 509, 171-182.
36. Marban E (2002). Cardiac channelopathies. Nature 415, 213-218.
37. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR & Kass RS (2002). Requirement of a macromolecular signaling complex for β adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295, 496-499.
38. Mitchell GF, Jeron A & Koren G (1998). Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274, H747-H751.
39. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H & Bennett V (2003). Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421, 634-639.
40. Morley GE, Vaidya D, Samie FH, Lo C, Delmar M & Jalife J (1999). Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10, 1361-1375.
41. + channel function in mice: What have we learned, and where do we go from here? Circ Res 89, 944-956.
42. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L, Vos MA, Dewerchin M, Benndorf K, Collen D, Carmeliet E & Carmeliet P (2001). Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7, 1021-1027.
43. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH & Ptacek LJ (2001). Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105, 511-519.
44. Rentschler S, Vaidya DM, Tamaddon H, Degenhardt K, Sassoon D, Morley GE, Jalife J & Fishman GI (2001). Visualization and functional characterization of the developing murine cardiac conduction system. Development 128, 1785-1792.
45. Romano C (1965). Congenital cardiac arrhythmia. Lancet 17, 658-659.
46. Salama G, Choi BR, Azour G, Lavasani M, Tumbev V, Salzberg BM, Patrick MJ, Ernst LA & Wagonner AS (2005). Properties of new, long-wavelength, voltage-sensitive dyes in the heart. J Membr Biol 208, 125-140.
47. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 93, 2208-2212.
48. Schwartz PF & Priori SG (2004). Long QT syndrome - Genotype phenotype considerations. In Cardiac Electrophysiology: From Cell to Bedside, 4th edn, ed. Zipes DP & Jalife P, pp. 651-659. Saunders, Philadelphia.
49. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR & Bloise R (2000). A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 343, 262-267.
50. Shusterman V, Usiene I, Harrigal C, Lee JS, Kubota T, Feldman AM & London B (2002). Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. Am J Physiol Heart Circ Physiol 282, H2076-H2083.
51. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC & Keating MT (2004). Ca V 1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31.
52. Tamaddon HS, Vaidya D, Simon AM, Paul DL, Jalife J & Morley GE (2000). High-resolution optical mapping of the right bundle branch in connexin40 knockout mice reveals slow conduction in the specialized conduction system. Circ Res 87, 929-936.
53. Trepanier-Boulay V, St-Michel C, Tremblay A & Fiset C (2001). Gender-based differences in cardiac repolarization in mouse ventricle. Circ Res 89, 437-444.
54. VanderBrink BA, Sellitto C, Saba S, Link MS, Zhu W, Homoud MK, Estes NA 3rd, Paul DL & Wang PJ (2000). Connexin40-deficient mice exhibit atrioventricular nodal and infra-Hisian conduction abnormalities. J Cardiovasc Electrophysiol 11, 1270-1276.
55. Wang L & Duff HJ (1997). Developmental changes in transient outward current in mouse ventricle. Circ Res 81, 120-127.
56. Ward OC (1964). A new familial cardiac syndrome in children. J Ir Med Assoc 54, 103-106.
57. + channel subunit in the mouse heart. Circ Res 85, 1067-1076.
58. Xu H, Barry DM, Li H, Brunet S, Guo W & Nerbonne JM (1999). Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 α subunit. Circ Res 85, 623-633.
59. K1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol 533, 697-710.
60. Zhou Z, Gong Q, Epstein ML & January CT (1998). HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem 273, 21061-21066.